Drug promo police slap Bausch Health with untitled letter over psoriasis drug TV and digital marketing – Endpoints News

Nearly every clinical trial, regardless of indication or phase, should be agile—incorporating technology and decentralized approaches—to make drug and therapy development faster, easier and more representative.

60 Years of Excluding Patients

For more than 60 years, the traditional clinical trial model has relied on a disparate network of independent investigator sites to find, enroll, and matriculate patients through a study to determine drug efficacy and safety. To participate, each of these sites must establish their own processes, people, and technology to accommodate clinical trials, which creates a significant barrier to entry. As a result, less than three percent1 of all healthcare providers participate as clinical trial investigators.

Leave a Reply

Your email address will not be published.